
Norway's Equinor will inject nearly $1 billion into Orsted's $9.4 billion rights issue, maintaining its 10% stake to bolster the Danish offshore wind developer amidst U.S. policy setbacks under the Trump administration and broader industry cost pressures. This significant capital infusion, which saw Orsted's shares rise up to 4.7% after an 85% decline from 2021 peaks, underscores a necessary industry consolidation and strategic collaboration in the offshore wind sector, with Norway's sovereign wealth fund also participating in the capital raise.
Norway's Equinor is injecting nearly $1 billion into Orsted's emergency $9.4 billion rights issue, a defensive move to stabilize the Danish offshore wind developer amid significant sector-wide and political challenges. Orsted's valuation has plummeted 85% from its 2021 peak, a consequence of both soaring inflation and logistical costs impacting the entire offshore wind industry, and direct hostility from the U.S. Trump administration which has suspended licensing. The capital infusion, supported by major shareholders including the Danish state (>50%) and Norway's sovereign wealth fund (~3%), provided a lifeline that spurred an immediate 4.7% rise in Orsted's share price. For Equinor, this move was largely compulsory to avoid dilution of its 10% stake, a position RBC analysts described as being 'between a rock and a hard place.' Equinor's intention to nominate a board director and seek 'closer industrial collaboration' suggests it is protecting its long-term strategic bet on renewables by taking a more active role, signaling potential future consolidation within the challenged sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.15
Ticker Sentiment